SCHEMBL30748915

SCHEMBL30748915

CCNc1ncnc2c1C(C)(C)C(=O)N2c1ccc(N2CCOCC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.40
JAK3 P52333 3/20 0.38
POLB P06746 2/20 0.37
TTBK1 Q5TCY1 1/20 0.36
TTBK2 Q6IQ55 1/20 0.36
PRKDC P78527 3/20 0.36
MAPT P10636 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
HTT P42858 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
GAA P10253 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALOX12 P18054 1/20 0.36
MAPK1 P28482 1/20 0.35
AHR P35869 1/20 0.35
JAK2 O60674 2/20 0.35
JAK1 P23458 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30748722 0.88 TTBK1 (0.38) JAK3POLBTTBK1TTBK2PRKDC
SCHEMBL30749038 0.82 ADORA3 (0.39) ADORA3JAK3POLBMAPTNPC1
SCHEMBL30749100 0.81 PRKDC (0.42) PRKDCMAPTRAB9AALDH1A1
SCHEMBL30749058 0.77 ADORA3 (0.36) ADORA3JAK3POLBMAPTRAB9A
SCHEMBL30748952 0.74 SYK (0.37) JAK3POLBMAPTNPC1RAB9A
SCHEMBL30748787 0.73 L3MBTL1 (0.36) JAK3POLBMAPTRAB9AHTT
SCHEMBL30748933 0.71 SYK (0.40) JAK3MAPTL3MBTL1GAAKDM4E
SCHEMBL30749016 0.71 SYK (0.36) JAK3L3MBTL1JAK2JAK1ALDH1A1
SCHEMBL30748860 0.70 RAD52 (0.33) ADORA3MAPTNPC1RAB9AMAPK1
SCHEMBL30748754 0.69 XDH (0.36) MAPTHTTL3MBTL1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565588-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF Suzhou Keen Therapeutics Co., Ltd. (CN) 2025-06-11 EP disclosed
WO-2023241620-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) 2023-12-21 WO disclosed